Greenville, MS10 Active Studies

Atopic Dermatitis Clinical Trials in Greenville, MS

Find 10 actively recruiting atopic dermatitis clinical trials in Greenville, MS. Connect with local research sites and explore new treatment options.

10
Active Trials
8
Sponsors
1,440
Enrolling

Recruiting Atopic Dermatitis Studies in Greenville

NCT06807281Recruiting

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in children 2 years of age or older with moderate-to-severe ...

Greenville, MS500 participantsPfizer
View Study Details
NCT05719558Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

The main aims of this study are: * To check the safety of ASP1002 in people with certain solid tumors. * To check if the people can tolerate ASP1002. * To find a suitable dose of ASP1002. This study ...

Greenville, MS210 participantsAstellas Pharma Global Development, Inc.
View Study Details
NCT06807268Recruiting

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 years of age who have moderate-to-severe eczema. Research study...

Greenville, MS150 participantsPfizer
View Study Details
NCT06898450Recruiting

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main qu...

Greenville, MS134 participantsNimbus Wadjet, Inc.
View Study Details
NCT06496750Recruiting

Ketamine for Methamphetamine Use Disorder

This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week rando...

Greenville, MS120 participantsUniversity of Texas Southwestern Medical Center
View Study Details
NCT05277168Recruiting

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to determine maximum tolerated dose (MTD) and/or...

Greenville, MS83 participantsJiangsu HengRui Medicine Co., Ltd.
View Study Details
NCT05892718Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

The purpose of this study is to find out whether IV injection of HCB101 is an effective treatment for different types of advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma and what ...

Greenville, MS80 participantsFBD Biologics Limited
View Study Details
NCT05269316Recruiting

Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of IMP9064 as monotherapy or in combination with PARP inhibitor Senaparib in patients with advanced solid tumors...

Greenville, MS61 participantsImpact Therapeutics, Inc.
View Study Details
NCT04389281Recruiting

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

In this Phase I trial for subjects with advanced head \& neck cancer, breast cancer, soft tissue sarcoma or melanoma all subjects will receive open label X-PACT treatment as a intra-tumoral injection....

Greenville, MS52 participantsImmunolight, LLC
View Study Details
NCT06487624Recruiting

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

The purpose of this study is to find out whether IV injection of HCB301 is an effective treatment for different types of advanced solid tumors and relapsed and refractory classical Hodgkin lymphomas a...

Greenville, MS50 participantsFBD Biologics Limited
View Study Details

About Atopic Dermatitis Clinical Trials in Greenville

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 10 atopic dermatitis clinical trials recruiting participants in Greenville, MS. These studies are seeking a combined 1,440 participants. Research is being sponsored by Pfizer, Astellas Pharma Global Development, Inc., Nimbus Wadjet, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Greenville — FAQ

Are there atopic dermatitis clinical trials in Greenville?

Yes, there are 10 atopic dermatitis clinical trials currently recruiting in Greenville, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 10 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 13, 2026 from ClinicalTrials.gov